Champions Oncology, Inc. (CSBR)
4.995
+0.06
(+1.32%)
USD |
NASDAQ |
Aug 31, 16:00
Champions Oncology Cash and Short Term Investments (Quarterly) : 4.872M for April 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 4.872M |
| January 31, 2026 | 7.127M |
| October 31, 2025 | 8.516M |
| July 31, 2025 | 10.32M |
| April 30, 2025 | 9.785M |
| January 31, 2025 | 3.202M |
| October 31, 2024 | 2.754M |
| July 31, 2024 | 2.892M |
| April 30, 2024 | 2.618M |
| January 31, 2024 | 4.468M |
| October 31, 2023 | 5.513M |
| July 31, 2023 | 4.869M |
| April 30, 2023 | 10.12M |
| January 31, 2023 | 11.64M |
| October 31, 2022 | 10.83M |
| July 31, 2022 | 8.058M |
| April 30, 2022 | 9.007M |
| January 31, 2022 | 8.701M |
| October 31, 2021 | 4.781M |
| July 31, 2021 | 3.998M |
| April 30, 2021 | 4.687M |
| January 31, 2021 | 7.429M |
| October 31, 2020 | 8.553M |
| July 31, 2020 | 6.943M |
| April 30, 2020 | 8.342M |
| Date | Value |
|---|---|
| January 31, 2020 | 3.282M |
| October 31, 2019 | 2.784M |
| July 31, 2019 | 2.202M |
| April 30, 2019 | 3.237M |
| January 31, 2019 | 3.31M |
| October 31, 2018 | 1.956M |
| July 31, 2018 | 1.016M |
| April 30, 2018 | 0.856M |
| January 31, 2018 | 1.062M |
| October 31, 2017 | 0.66M |
| July 31, 2017 | 0.43M |
| April 30, 2017 | 3.295M |
| January 31, 2017 | 3.488M |
| October 31, 2016 | 4.328M |
| July 31, 2016 | 4.463M |
| April 30, 2016 | 2.585M |
| January 31, 2016 | 3.293M |
| October 31, 2015 | 4.157M |
| July 31, 2015 | 6.76M |
| April 30, 2015 | 9.357M |
| January 31, 2015 | 0.182M |
| October 31, 2014 | 0.575M |
| July 31, 2014 | 3.052M |
| April 30, 2014 | 5.891M |
| January 31, 2014 | 5.812M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 502.69M |
| Avantor, Inc. | 306.80M |
| Personalis, Inc. | 212.66M |
| Adaptive Biotechnologies Corp. | 344.26M |
| 10X Genomics, Inc. | 552.03M |